Entera Bio
(NASDAQ:ENTX)
Entera Bio Ltd. - Ordinary Shares is expected to split Monday, August 15, 2022 with a ratio of 1:5
Entera Bio Ltd. - Ordinary Shares recently split on Friday, August 12, 2022 with a ratio of 1:3
$1.91
At close: Aug 11
$1.97
0.0600[3.14%]
PreMarket: 8:53AM EDT
Day High/Low- - -
52 Week High/Low1.31 - 3.51
Open / Close- / -
Float / Outstanding24.8M / 28.8M
Vol / Avg.- / 33.5K
Mkt Cap55M
P/E-
50d Avg. Price1.69
Div / Yield-
Payout Ratio-
EPS-0.13
Total Float24.8M

Entera Bio (NASDAQ:ENTX), Quotes and News Summary

Entera Bio (NASDAQ: ENTX)

Day High/Low- - -
52 Week High/Low1.31 - 3.51
Open / Close- / -
Float / Outstanding24.8M / 28.8M
Vol / Avg.- / 33.5K
Mkt Cap55M
P/E-
50d Avg. Price1.69
Div / Yield-
Payout Ratio-
EPS-0.13
Total Float24.8M
Entera Bio Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with significant unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The company's product candidates, EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are in clinical development. The company recently completed the phase 2 study for EB613. The company also licenses its technology to biopharmaceutical companies for use with their proprietary compounds and, to date, has established a collaboration with Amgen Inc.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Entera Bio Questions & Answers

Q
How do I buy Entera Bio (ENTX) stock?
A

You can purchase shares of Entera Bio (NASDAQ: ENTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Entera Bio's (ENTX) competitors?
A

There are no as such competitors for Entera Bio.

Q
What is the target price for Entera Bio (ENTX) stock?
A

The latest price target for Entera Bio (NASDAQ: ENTX) was reported by Goldman Sachs on Friday, August 12, 2022. The analyst firm set a price target for 21.00 expecting ENTX to rise to within 12 months (a possible 999.48% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Entera Bio (ENTX)?
A

The stock price for Entera Bio (NASDAQ: ENTX) is $1.91 last updated August 11, 2022, 8:00 PM UTC.

Q
Does Entera Bio (ENTX) pay a dividend?
A

The next Entera Bio (ENTX) dividend date is projected to be Monday, August 22, 2022.

Q
When is Entera Bio (NASDAQ:ENTX) reporting earnings?
A

Entera Bio’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Entera Bio (ENTX) going to split?
A

There is no upcoming split for Entera Bio.

Q
What sector and industry does Entera Bio (ENTX) operate in?
A

Entera Bio is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.